FDA device listing

HEMOSIL FACTOR XIII ANTIGEN

FDA device listing 2059628939 · Instrumentation Laboratory Co.

Key facts

Proprietary names HEMOSIL FACTOR XIII ANTIGEN
Owner/operator Instrumentation Laboratory Co.
Owner/operator number 1217183
Product codes DBT
Device names DBT - Factor Xiii A, S, Antigen, Antiserum, Control
Device class Class I
Classification regulations (21 CFR) 866.5330
Review panels Immunology
Registered establishments INSTRUMENTATION LABORATORY CO., INSTRUMENTATION LABORATORY CO. - Devens
Establishment registrations 1217183, 3037000637
FEI numbers 1217183, 3037000637
Establishment operations Repackager/Relabeler, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • None listed Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings